Home Treatment of Patients with Low-Risk Pulmonary Embolism with the Oral Factor Xa Inhibitor Rivaroxaban Rationale and Design of the Hot-Pe Trial
AuthID
P-00K-MJC
P-00K-MJC
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service